|
RNF146 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.288000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.354200E-01 |
| Normal-vs-Stage2 |
9.594200E-01 |
| Normal-vs-Stage3 |
7.052200E-02 |
| Normal-vs-Stage4 |
2.278300E-02 |
| Stage1-vs-Stage2 |
4.893000E-01 |
| Stage1-vs-Stage3 |
3.381000E-01 |
| Stage1-vs-Stage4 |
3.027200E-01 |
| Stage2-vs-Stage3 |
1.655620E-01 |
| Stage2-vs-Stage4 |
1.320190E-01 |
| Stage3-vs-Stage4 |
6.647400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.622600E-01 |
| Normal-vs-AfricanAmerican |
7.221800E-01 |
| Normal-vs-Asian |
4.473800E-02 |
| Caucasian-vs-AfricanAmerican |
7.195600E-01 |
| Caucasian-vs-Asian |
2.913800E-01 |
| AfricanAmerican-vs-Asian |
2.434400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.440000E-01 |
| Normal-vs-Female |
1.509430E-01 |
| Male-vs-Female |
2.620800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.528600E-01 |
| Normal-vs-Extreme_Weight |
1.517180E-01 |
| Normal-vs-Obese |
6.966600E-01 |
| Normal-vs-Extreme_Obese |
8.441800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.770000E-01 |
| Normal_Weight-vs-Obese |
4.363800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.559600E-01 |
| Extreme_Weight-vs-Obese |
3.665000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.350400E-01 |
| Obese-vs-Extreme_Obese |
9.905000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.679200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.793400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.346370E-01 |
| Normal-vs-Age(81-100Yrs) |
5.318200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.589620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.691200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.909960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.044000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.149500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.645630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.717410E-01 |
| Normal-VS-Type2 PRCC |
6.804400E-04 |
| Normal-VS-KIRP CIMP |
1.822150E-04 |
| Normal-VS-Unclassified PRCC |
1.911640E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.76410000016925E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.62518999999861E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.029500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.306990E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.331400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.007800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.636400E-02 |
| Normal-vs-N1 |
3.571200E-01 |
| Normal-vs-N2 |
2.308600E-01 |
| N0-vs-N1 |
4.202600E-01 |
| N0-vs-N2 |
3.226200E-01 |
| N1-vs-N2 |
1.769160E-01 |
|
|
